Lv4
478 积分 2024-07-03 加入
Receptor CDCP1 Is a Potential Target for Personalized Imaging and Treatment of Poor Outcome HER2+, Triple-Negative, and Metastatic ER+/HER2− Breast Cancers
3天前
已完结
Mammaglobin, GATA-binding protein 3 (GATA3), and epithelial growth factor receptor (EGFR) expression in different breast cancer subtypes and their clinical significance
13天前
已完结
Overexpression of Epidermal Growth Factor Receptor (EGFR) and HER-2 in Bladder Carcinoma and Its Association with Patients’ Clinical Features
13天前
已关闭
Receptor CDCP1 Is a Potential Target for Personalized Imaging and Treatment of Poor Outcome HER2+, Triple-Negative, and Metastatic ER+/HER2− Breast Cancers
23天前
已完结
PD-L1 Expression Harmonization in Gastric Cancer Using 22C3 PharmDx and SP263 Assays
4个月前
已完结
177Lu-Labeled Antibody–Drug Conjugate: A Dual-Mechanistic Treatment Modality in Solid Tumors
5个月前
已完结
Construction and preclinical evaluation of a 124I-labelled bispecific antibody targeting PD-L1 and PD-L2
5个月前
已完结
89Zr-panitumumab Combined With 18F-FDG PET Improves Detection and Staging of Head and Neck Squamous Cell Carcinoma
5个月前
已完结
177Lu-Labeled Antibody–Drug Conjugate: A Dual-Mechanistic Treatment Modality in Solid Tumors
5个月前
已完结
Claudin 18.2 as a novel therapeutic target
7个月前
已完结
皖公网安备34019202002308
